mupirocin and Cheilitis

mupirocin has been researched along with Cheilitis* in 2 studies

Other Studies

2 other study(ies) available for mupirocin and Cheilitis

Article	Year
[Bacterial lip abscess in an immunocompetent patient]. Dermatology online journal, 2013, Apr-15, Volume: 19, Issue:4 Lip abscesses are a potentially serious condition rarely reported in the medical literature. This disease requires prompt diagnosis and treatment with hospitalization, intravenous antibiotics, and urgent surgical drainage. Clinical knowledge of this condition is essential to guide the differential diagnosis and correctly adapt the etiological treatment. The presence of necrotic and cavitated lesions requires ruling out immunosupression or methicillin-resistant agent. We report a necrotic and cavitated bacterial lip abscess caused by methicillin-sensitive Staphylococcus aureus in an immunocompetent male. Topics: Abscess; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cheilitis; Cloxacillin; Combined Modality Therapy; Drainage; Humans; Immunocompetence; Male; Mupirocin; Staphylococcal Skin Infections; Staphylococcus aureus	2013
Characterization and management of exfoliative cheilitis: a single-center experience. Oral surgery, oral medicine, oral pathology and oral radiology, 2013, Volume: 116, Issue:6 Exfoliative cheilitis (EC) is a rare inflammatory condition affecting the vermilion of the lips and characterized by production of a thick keratin scale. Given the limited available data, the approach to optimal management of EC remains unclear. The objective of this retrospective study was to characterize the clinical features, management, and outcomes of a series of patients with EC. Fifteen patients with a median age of 59 years and a female-to-male ratio of 2:1 were diagnosed with EC from 2000 to 2010. Parafunctional lip licking (53%) and a history of psychiatric disorders (40%) were common. Ten patients (66%) returned for follow-up, with an overall response rate (partial or complete) of 80% at a median of 2 months, most frequently associated with the use of topical calcineurin inhibitors or moisturizing agents. Management of EC with topical calcineurin inhibitors and moisturizing agents is associated with clinical improvement, but prospective trials are needed. Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biopsy; Cheilitis; Dermatologic Agents; Emollients; Female; Humans; Keratolytic Agents; Male; Middle Aged; Mupirocin; Petrolatum; Photomicrography; Retrospective Studies; Tacrolimus; Tretinoin	2013

Article

Year

[Bacterial lip abscess in an immunocompetent patient].

Dermatology online journal, 2013, Apr-15, Volume: 19, Issue:4

Lip abscesses are a potentially serious condition rarely reported in the medical literature. This disease requires prompt diagnosis and treatment with hospitalization, intravenous antibiotics, and urgent surgical drainage. Clinical knowledge of this condition is essential to guide the differential diagnosis and correctly adapt the etiological treatment. The presence of necrotic and cavitated lesions requires ruling out immunosupression or methicillin-resistant agent. We report a necrotic and cavitated bacterial lip abscess caused by methicillin-sensitive Staphylococcus aureus in an immunocompetent male.

Topics: Abscess; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cheilitis; Cloxacillin; Combined Modality Therapy; Drainage; Humans; Immunocompetence; Male; Mupirocin; Staphylococcal Skin Infections; Staphylococcus aureus

2013

Characterization and management of exfoliative cheilitis: a single-center experience.

Oral surgery, oral medicine, oral pathology and oral radiology, 2013, Volume: 116, Issue:6

Exfoliative cheilitis (EC) is a rare inflammatory condition affecting the vermilion of the lips and characterized by production of a thick keratin scale. Given the limited available data, the approach to optimal management of EC remains unclear. The objective of this retrospective study was to characterize the clinical features, management, and outcomes of a series of patients with EC. Fifteen patients with a median age of 59 years and a female-to-male ratio of 2:1 were diagnosed with EC from 2000 to 2010. Parafunctional lip licking (53%) and a history of psychiatric disorders (40%) were common. Ten patients (66%) returned for follow-up, with an overall response rate (partial or complete) of 80% at a median of 2 months, most frequently associated with the use of topical calcineurin inhibitors or moisturizing agents. Management of EC with topical calcineurin inhibitors and moisturizing agents is associated with clinical improvement, but prospective trials are needed.

Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biopsy; Cheilitis; Dermatologic Agents; Emollients; Female; Humans; Keratolytic Agents; Male; Middle Aged; Mupirocin; Petrolatum; Photomicrography; Retrospective Studies; Tacrolimus; Tretinoin

2013